IMARC Group has recently released a new research study titled “United States Infection Control Market Size, Share, Trends and Forecast by Type, End User, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

United States Infection Control Market Overview

The United States infection control market size was valued at USD 12.75 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 22.25 Billion by 2033, exhibiting a CAGR of 6.29% from 2025-2033. The market is expanding due to rising hospital-acquired infections (HAIs), stringent regulatory standards, and advancements in sterilization technologies. Additionally, increasing healthcare investments, adoption of single-use medical products, and demand for automated disinfection solutions are driving market growth across hospitals, laboratories, and pharmaceutical industries.

Key Market Highlights – United States Infection Control Market

✔ The United States infection control market is experiencing strong growth as healthcare facilities and public health initiatives emphasize prevention of hospital-acquired infections (HAIs) and improved patient safety.

✔ Rising awareness of infectious diseases and antimicrobial resistance is driving demand for advanced infection prevention products and protocols across hospitals, clinics, and long-term care centers.

✔ Increased focus on hand hygiene solutions, disinfectants, and surface sterilization technologies is enhancing infection control practices in both clinical and community settings.

✔ Expansion of diagnostic testing and point-of-care infection monitoring is supporting early detection and containment of pathogens, thereby reducing disease spread.

✔ Growth in ambulatory care, surgical centers, and outpatient facilities is boosting adoption of comprehensive infection control systems and equipment.

✔ Rising integration of eco-friendly and sustainable infection control products—such as biodegradable wipes and low-toxicity disinfectants—is aligning with environmental preferences and regulatory expectations.

✔ Increasing investment in training, compliance programs, and digital tracking tools is improving adherence to infection prevention standards and reporting accuracy.

✔ Expansion of telehealth, remote care platforms, and mobile health units is reinforcing infection control strategies that reduce unnecessary clinical visits and exposure risks.

✔ Strategic partnerships between healthcare providers, manufacturers, and public health organizations are accelerating product innovation and deployment of advanced infection control solutions.

✔ Continued emphasis on pandemic preparedness, vaccination awareness, and antimicrobial stewardship is expected to sustain long-term market demand and enhanced preventive care practices.

Request for a sample copy of the report:https://www.imarcgroup.com/united-states-infection-control-market/requestsample

Trends in the United States Infection Control Market

Several key trends are emerging within the United States infection control market, reflecting the ongoing evolution of infection prevention practices and technologies. One notable trend is the increasing integration of digital health solutions and data analytics in infection control strategies.

As the market approaches 2026, healthcare facilities are leveraging data-driven insights to monitor infection rates, identify outbreaks, and evaluate the effectiveness of infection control measures. This trend enables healthcare providers to make informed decisions and implement targeted interventions to reduce HAIs. Additionally, the demand for environmentally friendly and sustainable infection control products is gaining momentum, as healthcare organizations seek to minimize their ecological footprint while maintaining high standards of safety. Manufacturers are responding by developing eco-friendly disinfectants and packaging solutions.

 Furthermore, the rise of telehealth and remote monitoring is influencing infection control practices, as healthcare providers explore innovative ways to manage patient care while minimizing the risk of infection transmission. These trends indicate a dynamic landscape for the United States infection control market, where technology, sustainability, and data-driven approaches will play critical roles in shaping future growth and operational efficiency.

Market Dynamics of the United States Infection Control Market

Increasing Awareness of Healthcare-Associated Infections (HAIs)

The United States infection control market is experiencing significant growth driven by the increasing awareness of healthcare-associated infections (HAIs) among healthcare providers and patients. HAIs pose a serious threat to patient safety, leading to prolonged hospital stays, increased healthcare costs, and higher mortality rates. As hospitals and healthcare facilities strive to improve patient outcomes, there is a heightened focus on implementing effective infection control measures.

 This awareness is prompting healthcare organizations to invest in advanced infection control products, including disinfectants, sterilization equipment, and personal protective equipment (PPE). The overall United States infection control market size is expected to expand as healthcare facilities prioritize infection prevention strategies and compliance with regulatory standards.

Furthermore, public health campaigns aimed at educating both healthcare professionals and the general public about the importance of infection control are contributing to increased demand for innovative solutions that enhance safety and reduce the incidence of HAIs.

Technological Advancements in Infection Control Solutions

Another significant dynamic influencing the United States infection control market is the rapid technological advancements in infection control solutions. Innovations in product development, such as the introduction of advanced sterilization technologies, antimicrobial coatings, and automated disinfection systems, are transforming the landscape of infection prevention.

 These technologies not only improve the efficacy of infection control measures but also enhance operational efficiency in healthcare settings. The overall United States infection control market growth will be significantly impacted by the adoption of these cutting-edge solutions, which provide healthcare facilities with the tools necessary to effectively combat infections.

 For instance, the integration of UV-C light technology and electrostatic spraying for disinfection is gaining traction, allowing for thorough and efficient cleaning of surfaces and equipment. As manufacturers continue to invest in research and development to create innovative infection control products, the market is poised for substantial growth, addressing the evolving needs of healthcare providers and enhancing patient safety.

Regulatory Changes and Compliance Requirements

The evolving regulatory landscape and compliance requirements are crucial dynamics shaping the United States infection control market. Government agencies, such as the Centers for Disease Control and Prevention (CDC) and the Occupational Safety and Health Administration (OSHA), are continually updating guidelines to enhance infection prevention protocols in healthcare settings.

This regulatory scrutiny is driving healthcare facilities to adopt robust infection control measures to ensure compliance and safeguard patient health. The overall United States infection control market size is expected to grow as facilities invest in training, equipment, and technologies that align with these regulations. Additionally, the increasing emphasis on quality assurance and accreditation standards is encouraging healthcare organizations to prioritize infection control initiatives.

As compliance becomes a critical factor in healthcare operations, the demand for effective infection control solutions will continue to rise, fostering market growth and innovation in the sector.

United States Pharmacy Market Segmentation:

Analysis by Type:

  • Equipment
    • Disinfectors
      • Washers
      • Flushers
      • Ultrasonic Cleaners
    • Sterilization Equipment
      • Heat Sterilization
      • Low Temperature Sterilization 
      • Radiation Sterilization
      • Filtration-Based Sterilization
    • Others
  • Services
    • Contract Sterilization
      • ETO Sterilization
      • Gamma Sterilization 
      • E-Beam Sterilization
      • Steam Sterilization
    • Infectious Waste Disposal 
  • Consumables
    • Disinfectants
    • Sterilization Consumables
    • Personal Protective Equipment
    • Others

Analysis by End User:

  • Hospitals and Clinics
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

Regional Analysis:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

·         The US infection control market is very competitive and driven by strict healthcare regulations, the growing hospital-acquired infections (HAIs), and advanced sterilization technologies. The company’s focus on automated disinfection systems, antimicrobial coatings, and advanced PPE solutions for better infection prevention. Increased demand for single-use medical devices, sterilization services, and innovative barrier protection products has heightened the competition. Moreover, strategic partnerships among hospitals, pharmaceutical companies, and technology vendors are broadening the scope of the market. Growth in outpatient facilities and home health care services drives adoption. For instance, in February 2024, APIC announced its 2024 Strategic Partners to advance infection prevention. It supports education and infection control efforts in healthcare and other sectors with 15,000 members. Furthermore, the demand for regulation, technological innovation, and AI-based monitoring system integration is one of the primary determinants for this market dynamics and competitiveness.

Speak to An Analyst:

https://www.imarcgroup.com/request?type=report&id=20447&flag=C

Latest News and Developments:

  • In January 2024, ICP Medical, a division of TEAM Technologies, launched a new website to enhance user experience and streamline product access. It integrates infection control solutions, e-commerce capabilities, instructional resources, and industry-specific offerings for healthcare, industrial, and government markets.
  • In July 2024, BioVigil, a U.S. based company, reengineered its user badges with enhanced sensing technology, durability, and battery life to improve hand hygiene monitoring. The system tracks compliance, reduces HAIs, supports contact tracing, and ensures effective infection prevention in healthcare settings.
  • In November 2024, Ondine Biomedical announced its preparations for a U.S. Phase 3 trial in Q4 2024 after raising C$16 Million. The trial, in collaboration with HCA Healthcare, will assess Steriwave® nasal photodisinfection to reduce hospital-associated infections, antimicrobial resistance, and surgical site infections across 14 hospitals.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302